Role of CGRP-receptor component protein (RCP) in CLR/RAMP function

Current Protein and Peptide Science

Volumn 14, Issue 5, 2013, Pages 407-415

  Dickerson, Ian M ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Adrenomedullin; Calcitonin gene related peptide; Calcitonin like receptor; CGRP receptor component protein; Receptor activity modifying protein; Signal transduction; Trafficking

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR COMPONENT PROTEIN; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL MIGRATION; CYTOPLASM; GENETIC TRANSFECTION; HUMAN; HYPERTENSION; NONHUMAN; OOCYTE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; XENOPUS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84882709451     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990057     Document Type: Article

References (71)

1. McLatchie, L. M.; N. J. Fraser, M. J. Main, A. Wise, J. Brown, N. Thompson, R. Solari, M. G. Lee, and S. M. Foord. RAMPs regulate the transport and ligand specificity of the calcitonin- receptor- like receptor. Nature, 1998, 393(6683), 333-339.
2. Baukrowitz, T.; T. C. Hwang, A. C. Nairn, and D. C. Gadsby, Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle. Neuron, 1994, 12(3), 473-482.
3. Bear, C.E.; F. Duguay, A.L. Naismith, N. Kartner, J.W. Hanrahan, and J.R. Riordan. Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J. Biol. Chem., 1991, 266(29), 19142-19145.
4. Uezono, Y. J.; Bradley, C.; Min, N. A.; McCarty, M.; Quick, J. R.; Riordan, C.; Chavkin, K.; Zinn, H. A. Lester, and N. Davidson. Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels, 1993, 1(3), 233-241.
5. Wilcox, E. R.; and J. Fex. Construction of a cDNA library from microdissected guinea pig organ of Corti. Hear. Res., 1992, 62(1), 124-126.
6. Luebke, A. E.; G. P. Dahl; B. A. Roos; I. M. Dickerson. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc. Natl. Acad. Sci. USA., 1996, 93(8), 3455-3460.
7. Adams, J. C.; E. A. Mroz; and W.F. Sewell. A possible neurotransmitter role for CGRP in a hair-cell sensory organ. Brain Res., 1987, 419(1-2), 347-351.
8. Guillemare, E.; M. Lazdunski; and E. Honore. CGRP-induced activation of KATP channels in follicular Xenopus oocytes. Pflugers Arch., 1994, 428(5-6), 604-609.
9. Klein, S. L.; R. L. Strausberg; L. Wagner; J. Pontius; S. W. Clifton; and P. Richardson. Genetic and genomic tools for Xenopus research, The NIH Xenopus initiative. Dev. Dyn., 2002, 225(4), 384-391.
10. Kline, L. W.; T. Kaneko; K. W. Chiu; S. Harvey; and P. K. Pang. Calcitonin gene-related peptide in the bullfrog, Rana catesbeiana, localization and vascular actions. Gen. Comp. Endocrinol., 1988, 72(1), 123-129.
11. Birnbaum, A. K.; D. R. Wotta; P. Y. Law; and G. L. Wilcox. Functional expression of adrenergic and opioid receptors in Xenopus oocytes, interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res. Mol. Brain Res., 1995, 28(1), 72-80.
12. Wotta, D. R.; A. K. Birnbaum; G. L. Wilcox; R. Elde; and P. Y. Law. Mu-opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner. Brain Res. Mol. Brain Res., 1997, 44(1), 55-65.
13. Evans, B. N.; M. I. Rosenblatt; L. O. Mnayer; K. R. Oliver; and I. M. Dickerson. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem., 2000, 275(40), 31438-31443.
14. Prado, M.A.; B. Evans-Bain; K. R. Oliver; and I. M. Dickerson. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides, 2001, 22(11), 1773-1781.
15. Egea, S. C.; and I. M. Dickerson. Direct interactions between calcitonin- like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling. Endocrinology, 2012, 153(4), 1850-1860.
16. Gao, F.; K. G. Harikumar; M. Dong; P. C. Lam; P. M. Sexton; A. Christopoulos; A. Bordner; R. Abagyan; and L. J. Miller. Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol. Pharmacol., 2009, 76(2), 264-274.
17. Harikumar, K. G.; D. I. Pinon; and L. J. Miller. Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. J. Biol. Chem., 2007, 282(42), 30363-30372.
18. Ilegems, E.; K. Iwatsuki; Z. Kokrashvili; O. Benard; Y. Ninomiya; and R. F. Margolskee. REEP2 enhances sweet receptor function by recruitment to lipid rafts. J. Neurosci., 2010, 30(41), 13774-13783.
19. Simons, K.; and D. Toomre. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol., 2000, 1(1), 31-39.
20. Johnson, E. C.; O. T. Shafer; J. S. Trigg; J. Park; D. A. Schooley; J. A. Dow; and P. H. Taghert. A novel diuretic hormone receptor in Drosophila, evidence for conservation of CGRP signaling. J. Exp. Biol., 2005, 208(Pt 7), 1239-1246.
21. Conner, A. C.; J. Simms, S. G. Howitt, M. Wheatley, and D. R. Poyner. The second intracellular loop of the calcitonin gene-related peptide receptor provides molecular determinants for signal transduction and cell surface expression. J. Biol. Chem., 2006, 281(3), 1644-1651.
22. Ma, W.; J. G. Chabot; K. J. Powell; K. Jhamandas; I. M. Dickerson; and R. Quirion. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience, 2003, 120(3), 677-694.
23. Oliver, K. R.; A. Wainwright; A. M. Kinsey; R. P. Heavens; D. J. Sirinathsinghji and R. G. Hill. Regional and cellular localization of calcitonin gene-related peptide- receptor component protein mRNA in the guinea-pig central nervous system. Brain Res. Mol. Brain Res., 1999, 66(1-2), 205-210.
24. Pokabla, M. J.; I. M. Dickerson; and R. E. Papka. Calcitonin generelated peptide-receptor component protein expression in the uterine cervix, lumbosacral spinal cord, and dorsal root ganglia. Peptides, 2002, 23(3), 507-514.
25. Rosenblatt, M. I.; G. P. Dahl; and I. M. Dickerson. Characterization and localization of the rabbit ocular calcitonin gene- related peptide (CGRP)-receptor component protein (RCP). Invest. Ophthalmol. Vis. Sci., 2000, 41(5), 1159-1167.
26. Rossi, S. G.; I. M. Dickerson; and R. L. Rotundo. Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression. J. Biol. Chem., 2003, 278(27), 24994-5000.
27. Samuelson, U. E.; C. J. Dalsgaard; J. M. Lundberg; and T. Hokfelt. Calcitonin gene-related peptide inhibits spontaneous contractions in human uterus and fallopian tube. Neurosci. Lett., 1985, 62(2), 225-230.
28. Naghashpour, M.; M. I. Rosenblatt; I. M. Dickerson; and G. P. Dahl. Inhibitory effect of calcitonin gene-related peptide on myometrial contractility is diminished at parturition. Endocrinology, 1997, 138(10), 4207-4214.
29. Naghashpour, M.; and G. Dahl. Sensitivity of myometrium to CGRP varies during mouse estrous cycle and in response to progesterone. Am. J. Physiol. Cell Physiol., 2000, 278(3), C561-C569.
30. Brain, S. D.; T. J. Williams; J. R. Tippins; H. R. Morris; and I. MacIntyre. Calcitonin gene-related peptide is a potent vasodilator. Nature, 1985, 313(5997), 54-56.
31. Krootila, K.; H. Uusitalo; and A. Palkama. Effect of neurogenic irritation and calcitonin gene-related peptide (CGRP) on ocular blood flow in the rabbit. Curr. Eye Res., 1988, 7(7), 695-703.
32. Nuki, C.; H. Kawasaki; K. Kitamura; M. Takenaga; K. Kangawa; T. Eto; and A. Wada. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun., 1993 196(1), 245-251.
33. Gao, Y. J.; Y. Nishimura; A. Suzuki; and Y. Nakai. Calcitonin gene-related peptide-induced relaxation in isolated small superior mesenteric arteries from adult stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol., 1995, 22(Suppl 1), S109-S111.
34. Champion, H. C.; D. L. Akers; J. A. Santiago; D. G. Lambert; D. B. McNamara; and P. J. Kadowitz. Analysis of responses to human synthetic adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat. Mol. Cell Biochem., 1997, 176(1-2), 5-11.
35. Oliver, K. R.; A. Wainwright; L. Edvinsson; J. D. Pickard; and R. G. Hill. Immunohistochemical localization of calcitonin receptorlike receptor and receptor activity-modifying proteins in the human cerebral vasculature. J. Cereb. Blood Flow Metab., 2002, 22(5), 620-629.
36. Gangula, P. R.; H. Zhao; S. C. Supowit; S. J. Wimalawansa; D. J. Dipette; K. N. Westlund; R. F. Gagel; and C. Yallampalli. Increased blood pressure in alpha-calcitonin gene-related peptide/ calcitonin gene knockout mice. Hypertension, 2000, 35(1 Pt 2), 470-475.
37. Supowit, S. C.; C. V. Ramana; K. N. Westlund; and D. J. DiPette. Calcitonin gene-related peptide gene expression in the spontaneously hypertensive rat. Hypertension, 1993, 21(6 Pt 2), 1010-1014.
38. Westlund, K. N.; D. J. DiPette; J. Carson; and O. B. Holland. Decreased spinal cord content of calcitonin gene-related peptide in the spontaneously hypertensive rat. Neurosci. Lett., 1991, 131(2), 183-186.
39. Supowit, S. C.; A. Gururaj; C. V. Ramana; K. N. Westlund; and D. J. DiPette. Enhanced neuronal expression of calcitonin gene-related peptide in mineralocorticoid-salt hypertension. Hypertension, 1995, 25(6), 1333-1338.
40. Supowit, S. C.; H. Zhao; D. M. Hallman; and D. J. DiPette. Calcitonin gene-related peptide is a depressor of deoxycorticosteronesalt hypertension in the rat. Hypertension, 1997, 29(4), 945-950.
41. Hong, K. W.; S. S. Yu; Y. W. Shin; C. D. Kim; B.Y. Rhim; and W. S. Lee. Decreased CGRP level with increased sensitivity to CGRP in the pial arteries of spontaneously hypertensive rats. Life Sci., 1997, 60(10), 697-705.
42. Supowit, S. C.; K. A. Katki; T. W. Hein; P. Gupta; L. Kuo; I. M. Dickerson; and D. J. Dipette. Vascular reactivity to calcitonin generelated peptide is enhanced in subtotal nephrectomy-salt induced hypertension. Am. J. Physiol. Heart Circ. Physiol., 2011, 301(3), H683-H688.
43. Chiba, T. A.; Yamaguchi, T.; Yamatani, A.; Nakamura, T.; Morishita, T.; Inui, M.; Fukase, T.; Noda, and T. Fujita. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol., 1989, 256(2 Pt 1), E331-E335.
44. Han, Z. Q.; H. A. Coppock; D. M. Smith; S. Van Noorden; M. W. Makgoba; C. G. Nicholl; and S. Legon. The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J. Mol. Endocrinol., 1997, 18(3), 267-272.
45. Hasbak, P. K.; Eskesen, S.; Schifter; and L. Edvinsson. Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries. Br. J. Pharmacol., 2005, 145(5), 646-655.
46. Vause, C. V.; P. L. Durham. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogenactivated protein kinase pathways. J. Neurochem., 2009, 110(3), 811-821.
47. Zhang, L.; A. D. Bonev; G. M. Mawe; and M. T. Nelson. Protein kinase A mediates activation of ATP-sensitive K+ currents by CGRP in gallbladder smooth muscle. Am. J. Physiol., 1994, 267(3 Pt 1), G494-G499.
48. Drissi, H. F.; Lasmoles, V.; Le Mellay; P. J. Marie; and M. Lieberherr. Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J. Biol. Chem., 1998, 273(32), 20168-20174.
49. 2+ concentrations but not cyclic AMP formation in CGRP receptor- positive osteosarcoma cells (OHS-4). Cytokine, 1999, 11(3), 200-207.
50. Schiess, M.C.; B.J. Poindexter, B.S. Brown, and R.J. Bick, The effects of CGRP on calcium transients of dedifferentiating cultured adult rat cardiomyocytes compared to non-cultured adult cardiomyocytes, possible protective and deleterious results in cardiac function. Peptides, 2005, 26(3), 525-530.
51. Wang, Z.; W. Ma, J.G. Chabot, and R. Quirion, Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J. 2009, 23(8), 2576-86.
52. Yu, X.J.; C.Y. Li, K.Y. Wang, and H.Y. Dai, Calcitonin generelated peptide regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes by activation of ERK1/2 MAPK. Regul. Pep., 2006, 137(3), 134-139.
53. Schaeffer, C. D.; Vandroux, L.; Thomassin, P.; Athias, L.; Rochette, and J.L. Connat, Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim. Biophys. Acta, 2003, 1643(1-3), 65-73.
54. Gurevich, V.V.; S.B. Dion, J.J. Onorato, J. Ptasienski, C.M. Kim, R. Sterne-Marr, M.M. Hosey, and J.L. Benovic, Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2- adrenergic, and m2 muscarinic cholinergic receptors. J. Biol. Chem., 1995, 270(2), 720-731.
55. Gurevich, V.V.; and E.V. Gurevich, The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci., 2004, 25(2), 105-11.
56. Kang, J.; Y. Shi, B. Xiang, B. Qu, W. Su, M. Zhu, M. Zhang, G. Bao, F. Wang, X. Zhang, R. Yang, F. Fan, X. Chen, G. Pei, and L. Ma, A nuclear function of beta-arrestin1 in GPCR signaling, regulation of histone acetylation and gene transcription. Cell, 2005, 123(5), 833-847.
57. Reiter, E.; and R.J. Lefkowitz, GRKs and beta-arrestins, roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab., 2006, 17(4), 159-165.
58. Ferri, M.L.; G. Peyroche, M. Siaut, O. Lefebvre, C. Carles, C. Conesa, and A. Sentenac, A novel subunit of yeast RNA polymerase III interacts with the TFIIB-related domain of TFIIIB70. Mol. Cell Bio, 2000, 20(2), 488-495.
59. Siaut, M.; C.; Zaros, E.; Levivier, M.L.; Ferri, M.; Court, M.; Werner, I.; Callebaut, P.; Thuriaux, A.; Sentenac, and C.; Conesa, An Rpb4/Rpb7-like complex in yeast RNA polymerase III contains the orthologue of mammalian CGRP-RCP. Mol. Cell Biol., 2003, 23(1), 195-205.
60. Hu, P.; S. Wu, Y. Sun, C.C. Yuan, R. Kobayashi, M.P. Myers, and N. Hernandez, Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits. Mol. Cell Biol., 2002, 22(22), 8044-8055.
61. Nandha, K.A.; G.M. Taylor, D.M. Smith, A.A. Owji, P.G. Byfield, M.A. Ghatei, and S.R. Bloom, Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed. Regul. Pept., 1996, 62(2-3), 145-151.
62. Shindo, T.Y.; Kurihara, H.; Nishimatsu, N.; Moriyama, M.; Kakoki, Y.; Wang, Y.; Imai, A.; Ebihara, T.; Kuwaki, K.H.; Ju, N.; Minamino, K.; Kangawa, T.; Ishikawa, M.; Fukuda, Y.; Akimoto, H.; Kawakami, T.; Imai, H.; Morita, Y.; Yazaki, R.; Nagai, Y.; Hirata, and H. Kurihara, Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation, 2001, 104(16), 1964-1971.
63. Uddman, R.; L. Edvinsson, E. Ekblad, R. Hakanson, and F. Sundler, Calcitonin gene-related peptide (CGRP), perivascular distribution and vasodilatory effects. Regul. Pept., 1986, 15(1), 1-23.
64. Edvinsson, L.; Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. CNS Drug Rev., 2005, 11(1), 69-76.
65. Goadsby, P.J.; R.B. Lipton, and M.D. Ferrari, Migraine--current understanding and treatment. N. Engl. J. Med., 2002, 346(4), 257-70.
66. Ho, T.W.; L.K. Mannix, X. Fan, C. Assaid, C. Furtek, C.J. Jones, C.R. Lines, and A.M. Rapoport, Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology, 2007.
67. Lassen, L.H.; P.A. Haderslev, V.B. Jacobsen, H.K. Iversen, B. Sperling, and J. Olesen, CGRP may play a causative role in migraine. Cephalalgia, 2002, 22(1), 54-61.
68. Clementi, G. A.; Caruso, V.M.; Cutuli, A.; Prato, E.; de Bernardis, C.E.; Fiore, and M. Amico-Roxas. Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation. Life Sci., 1995, 57(14), p. PL193-197.
69. Gomes, R.N.; H.C. Castro-Faria-Neto, P.T. Bozza, M.B. Soares, C.B. Shoemaker, J.R. David, and M.T. Bozza, Calcitonin generelated peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock, 2005, 24(6), 590-594.
70. Gram, D.X.; A.J. Hansen, M. Wilken, T. Elm, O. Svendsen, R.D. Carr, B. Ahren, and C.L. Brand, Plasma calcitonin generelated peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur. J.; Endocrinol., 2005, 153(6), 963-969.
71. Zelissen, P.M.; H.P. Koppeschaar, C.J. Lips, and W.H. Hackeng, Calcitonin gene-related peptide in human obesity. Peptides, 1991, 12(4), 861-863.